| 标题 |
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:María‐Victoria Mateos; Bruno Paiva; María‐Teresa Cedena; Noemí Puig; Anna Sureda-Balarí; et al 出版日期:2025-08-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)